Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants have?
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants has 53 citations in the OpenAlex counts ScholarIQ stores.
When was Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants published?
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants has 2023 year in the ScholarIQ index.
What is the open-access status of Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants?
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants has hybrid oa status in the ScholarIQ index.
What is the DOI of Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants?
The DOI for Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants is on the source record.
What is the PMID of Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants?
The PMID for Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants is on the source record.
What is the OpenAlex record for Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants?
The OpenAlex for Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants is on the source record.